Cardiological and Psychological Mobile Care through Telematic Technologies for Heart Failure Patients: ICAROS Project

  • A. Compare
  • E. Molinari
  • L. Bellardita
  • A. Villani
  • G. Branzi
  • G. Malfatto
  • S. Boarin
  • M. Cassi
  • A. Gnisci
  • G. Parati


Currently heart failure is one of the main causes of disability and mortality in western countries. Due to the severity of this illness, as well as the number of clinical interventions necessary (particularly the high frequency of hospitalizations), heart failure comprises a major health expense. Specifically, it accounts for 5% of total hospitalization costs and 1–2% of total healthcare expenses [1]. Better therapies for myocardial infarction (MI) and an increasingly older population will eventually result in even larger numbers of patients with chronic heart failure. Obviously, the increase of patients will necessitate new interventions and support models, including multi-pharmacological prescriptions and close monitoring of clinical conditions over extended periods.Because a patient’s psychological condition can influence the course of cardiac disease and therapeutic compliance, the interventions also will need to monitor behavioral and life-style modifications, requiring extensive education efforts, both for the patients themselves and for their families.


Cardiac Rehabilitation Electronic Patient Record Chronic Heart Failure Patient Congestive Heart Failure Patient Unplanned Readmission 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cline CM, Israelsson BY, Willenheimer RB et al (1998) Cost effective management programme for heart failure reduces hospitalisation. Heart 80:442–446PubMedGoogle Scholar
  2. 2.
    Weingarten SR, Henning JM, Badamgarav E et al (2002) Interventions used in disease management programmes for patients with chronic illness-which ones work? Metaanalysis of published reports. BMJ:325Google Scholar
  3. 3.
    Gattis WA, Hasselblad V, Whellan DJ, O’Connor M (1999) Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the pharmacist in heart failure assessment recommendation and monitoring (PHARM) study. Arch Intern Med 159:1939–1945CrossRefPubMedGoogle Scholar
  4. 4.
    Stewart S, Marley JE, Horowitz JD (1999) Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet 354:1077–1083CrossRefPubMedGoogle Scholar
  5. 5.
    Andersson EB, Ehnfors M, Matejka G et al (1998) Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. Eur Heart J 19:1254–1260CrossRefPubMedGoogle Scholar
  6. 6.
    Oddone EZ, Weinberger M, Giobbie-Hurder A et al (1999) Enhanced access to primary care for patients with congestive heart failure. Veterans affairs cooperative study group on primary care and hospital readmission. Eff Clin Pract 2:201–209PubMedGoogle Scholar
  7. 7.
    Rich MW, Beckham V, Wittenberg C et al (1995) A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333:1190–1195CrossRefPubMedGoogle Scholar
  8. 8.
    Rich MW, Vinson JM, Sperry JC et al (1993) Prevention of readmission in elderly patients with congestive heart failure: results of a prospective, randomized pilot study. J Gen Intern Med 8:585–590CrossRefPubMedGoogle Scholar
  9. 9.
    Rich MW (1999) Heart failure disease management: a critical review. J Cardiac Fail 5:64–75CrossRefGoogle Scholar
  10. 10.
    Stewart S, Horowitz JJD (2002) Detecting early clinical deterioration in chronic heart failure patients post-acute hospitalisation — a critical component of multidisciplinary, home-based intervention. Eur J Heart Fail 4:345–351CrossRefPubMedGoogle Scholar
  11. 11.
    Schulman KA, Mark DB, Califf RM (1998) Outcomes and costs within a disease management program for advanced congestive heart failure. Amer Heart J 135:285–292CrossRefGoogle Scholar
  12. 12.
    Grady KL, Dracupp K, Kennedy G et al (2000) Team management of patients with heart failure. Circulation 102:2443–2456PubMedGoogle Scholar
  13. 13.
    Shah NB, Der E, Ruggiero C et al (1998) Prevention of hospitalisations fro heart failure with an interactive home monitoring program. Am Hearth J 135:373–378CrossRefGoogle Scholar
  14. 14.
    Stewart S, Horowitz JD (2002) Home based intervention in congestive heart failure. Long-term implications on readmission and survival. Detecting early clinical deterioration in chronic heart failure patients post-acute hospitalisation — a critical component of multidisciplinary, home-based intervention. Circulation 105:2861–2866CrossRefPubMedGoogle Scholar
  15. 15.
    Akosah KO, Shaper AM, Havlik P et al (2002) Improving care for patients with chronic heart failure in the community. The importance of a disease management program. Chest J 122:906–912CrossRefGoogle Scholar
  16. 16.
    Whellan DJ, Gaulden L, Gattis WA et al (2001) The benefit of implementing a heart failure disease management program. Arch Intern Med 161:2223–2228CrossRefPubMedGoogle Scholar
  17. 17.
    Krumholz HM, Parent EG, Tu N et al (1997) Readmission after hospitalisation for congestive heart failure among medicare beneficiaries. Arch Intern Med 157:99–104CrossRefPubMedGoogle Scholar
  18. 18.
    Cleland JG, Cohen-Solai A, Cosin Aguilar J et al (2002) Management of heart failure in primary care (the IMPROVEMENT of heart failure program): an international survey. Lancet 360:1631–1639CrossRefPubMedGoogle Scholar
  19. 19.
    Brass-Mynderse NJ (1996) Disease management for chronic congestive heart failure. J Cardiovasc Nurs 11:54–62PubMedGoogle Scholar
  20. 20.
    Naylor MD, Brooten D, Campbell R et al (1999) Comprehensive discharge planning and home follow-up of hospitalised elders. A randomised clinical trial. JAMA 281:613–620CrossRefPubMedGoogle Scholar
  21. 21.
    Jerant AF, Azari R, Nesbitt TS (2001) Reducing the cost of frequent hospital admissions for congestive hearth failure. A randomised trial of a home telecare intervention. Medical Care 39:1234–1245CrossRefPubMedGoogle Scholar
  22. 22.
    de Luigan S, Wells S, Johonson P et al (2001) Compliance and effectiveness of 1 year’s home telemonitoring.The report of a pilot study of patients with chronic heart failure. Eur J Heart Fail 3:723–730CrossRefGoogle Scholar
  23. 23.
    Kornowsky R, Zeeli D, Averbuch M et al (1995) Intensive home-care surveillance prevents hospitalisation and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J 129:762–766CrossRefGoogle Scholar
  24. 24.
    Gattis WA, Hasselblad V, Whellan DJ, O’Connor CM (1999) Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team. Arch Intern Med 159:1939–1945CrossRefPubMedGoogle Scholar
  25. 25.
    Stewart S, Vandenbroek AJ, Pearson S, Horowitz JD (1999) Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure. Arch Intern Med 159:257–261CrossRefPubMedGoogle Scholar
  26. 26.
    Ekman I, Swedberg K (2002) Home-based management of patients with chronic heart failure-focus on content not just form! Eur Heart J 23: 1323–1325CrossRefPubMedGoogle Scholar
  27. 27.
    Spielberger CD, Sydeman S, Owen AE, Marsh BJ (1999) Measuring anxiety and anger with the State-Trait Anxiety Inventory (STAI) and the State-Trait Anger Expression Inventory (STAXI). In:Maruish ME (Ed) The use of psychological testing for treatment planning and outcomes assessment 2 edn. Lawrence Erlbaum Associates, Publishers, Mahwah, NJ, US pp 993–1021Google Scholar
  28. 28.
    Spielberger CD, Sydeman S (1994) State-trait anxiety inventory and state-trait anger expression inventory. In: Maruish ME (Ed) The use of psychological testing for treatment planning and outcome assessment. Lawrence Erlbaum Associates, Inc, Hillsdale, NJ, England pp 292–321Google Scholar
  29. 29.
    Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606–13CrossRefPubMedGoogle Scholar
  30. 30.
    Kroenke K, Spitzer RL, Williams JB (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. JAMA 282:1737–44CrossRefPubMedGoogle Scholar
  31. 31.
    Lowe B, Kroenke K, Herzog W, Grafe K (2004) Measuring depression outcome with a brief self-report instrument: sensitivity to change of the patient health questionnaire (PHQ-9). J Affect Disord 81:61–66CrossRefPubMedGoogle Scholar
  32. 32.
    Wool C, Cerutti R, Marquis P et al (2000) Psychometric validation of two Italian quality of life questionnaires in menopausal women. Maturitas 35:129–142CrossRefPubMedGoogle Scholar
  33. 33.
    Badia X, Gutierrez F, Wiklund I, Alonso J (1996) Validity and reliability of the Spanish version of the psychological general well-being index. Quality of life research: an International Journal of Quality of Life:Aspects of Treatment. Care & Rehabilitation 5:101–108Google Scholar
  34. 34. Scholar

Copyright information

© Springer-Verlag Italia 2006

Authors and Affiliations

  • A. Compare
    • 1
  • E. Molinari
    • 2
  • L. Bellardita
    • 3
  • A. Villani
    • 4
  • G. Branzi
    • 4
  • G. Malfatto
    • 4
  • S. Boarin
    • 4
  • M. Cassi
    • 5
  • A. Gnisci
    • 6
  • G. Parati
    • 7
  1. 1.Department of PsychologyCatholic University of MilanMilan
  2. 2.Faculty of Clinical PsychologyCatholic UniversityMilanItaly
  3. 3.University of BergamoCatholic University of MilanItaly
  4. 4.Cardiology II St. Luca HospitalItalian Auxologic InstituteMilanItaly
  5. 5.Mobile Medical TechnologiesGenoaItaly
  6. 6.II UniversityNaplesItaly
  7. 7.Department of Clinical Medicine, Prevention and Applied BiotechnologyUniversity of Milano-BicoccaItaly

Personalised recommendations